Nebenwirkungen · Insuman
Insuman Comb 15 100 IU/ml suspension for injection in a vial Insuman Comb 15 100 IU/ml suspension for injection in a cartridge Insuman Comb 15 SoloStar 100 IU/ml suspension for injection in a pre-filled pen · Abschnitt 4.8 · PDF-Seite 39–40
HOS-088655 · Präparat HOS-083671
Summary of the safety profile Hypoglycaemia, in general the most frequent adverse reaction of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement. In clinical studies and during marketed 39 use, the frequency varies with patient population and dose regimens. Therefore, no specific frequency can be presented.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-05T14:48:00Z · SHA-256 361eee512a62ae9d440e9dc3368e92bfdf642f50b791ed122087c5b884c15e02 · Passage 9cabc00187fefe028080497dc433b6b8d5e9a05db8678292d69fff1158bc86d9 · Zeichen 0–407 im Abschnitt